Enovis Corporation
NYSE:ENOVMedical - Devices
+$0.73 today
- Market cap
- $1.56B
- Beta
- 1.49
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$20.02
Volume 0.88M
Average 0.99M
Income Statement
Follow revenue through to earnings.
Revenue
$2.25B
FY 2025 · Annual
+6.7% YoYOperating Income
-$18.87M
FY 2025 · Annual
Net Income
-$1.18B
FY 2025 · Annual
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.43B | 1.56B | 1.71B | 2.11B | 2.25B |
| Cost of Revenue | 648.51M | 693.72M | 716.42M | 926.87M | 902.79M |
| Gross Profit | 777.68M | 869.38M | 990.78M | 1.18B | 1.35B |
| Gross Margin | 54.5% | 55.6% | 58.0% | 56.0% | 59.8% |
| Research & Development | 49.09M | 60.83M | 75.33M | 91.3M | 120.33M |
| Selling, General & Admin | 665.78M | 772.91M | 830.31M | 939.36M | 1.07B |
| Operating Expenses | 840.47M | 940.56M | 1.06B | 1.96B | 1.36B |
| Depreciation & Amortization | 262.92M | 219.71M | 217.11M | 284.8M | 294.38M |
| EBITDA | 170.25M | 241.69M | 169.73M | (481.03M) | (830.22M) |
| EBITDA Margin | 11.9% | 15.5% | 9.9% | -22.8% | -36.9% |
| Operating Income | (62.8M) | (71.18M) | (65.71M) | (775.72M) | (18.87M) |
| Operating Margin | -4.4% | -4.6% | -3.8% | -36.8% | -0.8% |
| Interest Income | 0 | 200K | 0 | 0 | 0 |
| Interest Expense | 29.11M | 24.95M | 19.75M | 57.1M | 34.82M |
| Other Income / Expenses | (58.98M) | 69.11M | (1.42M) | (47.21M) | (1.14B) |
| Income Before Tax | (121.78M) | (2.07M) | (67.13M) | (822.92M) | (1.16B) |
| Pre-Tax Margin | -8.5% | -0.1% | -3.9% | -39.0% | -51.6% |
| Income Tax Expense | (19.53M) | 36.12M | (13.29M) | 4.49M | 22.29M |
| Net Income | 71.66M | (13.29M) | (33.26M) | (825.49M) | (1.18B) |
| Net Margin | 5.0% | -0.9% | -1.9% | -39.2% | -52.7% |
| EPS (Basic) | (2.02) | (0.28) | (0.61) | (14.93) | (20.86) |
| EPS (Diluted) | (2.02) | (0.28) | (0.61) | (14.93) | (20.86) |
| 51.14M | 54.07M | 54.53M | 55.28M | 56.79M | |
| 51.14M | 54.07M | 54.49M | 55.28M | 56.79M |
ENOV Earnings Waterfall · TTM
NYSE:ENOV · Revenue to Net Income
Key Ratios
Analysis
$2.3B of revenue converted into -$1.1B of net income for the selected period. Gross margin is 56.8% and net margin is -50.6%, showing how much revenue survives after costs and taxes. EPS is $-20.02, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
ITT Inc.
NYSE:ITT
Market cap
$18.84B
IDEX Corporation
NYSE:IEX
Market cap
$17.45B
Watts Water Technologies, Inc.
NYSE:WTS
Market cap
$12.03B
Donaldson Company, Inc.
NYSE:DCI
Market cap
$10.04B
The Middleby Corporation
NASDAQ:MIDD
Market cap
$6.11B
EnPro Industries, Inc.
NYSE:NPO
Market cap
$5.79B
Franklin Electric Co., Inc.
NASDAQ:FELE
Market cap
$4.34B
Kadant Inc.
NYSE:KAI
Market cap
$3.47B
Enerpac Tool Group Corp.
NYSE:EPAC
Market cap
$2.02B
The Gorman-Rupp Company
NYSE:GRC
Market cap
$1.84B
Helios Technologies, Inc.
NYSE:HLIO
Market cap
$1.53B
Graham Corporation
NYSE:GHM
Market cap
$979.18M
Luxfer Holdings PLC
NYSE:LXFR
Market cap
$464.01M
Omega Flex, Inc.
NASDAQ:OFLX
Market cap
$236.61M
Hurco Companies, Inc.
NASDAQ:HURC
Market cap
$131.92M
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 |
How much revenue does ENOV generate?
Enovis Corporation (ENOV) reported $2.25B of revenue in fiscal 2025.
Is ENOV profitable?
Enovis Corporation (ENOV) reported -$1.18B of net income, with a net margin of -52.7%.
Continue the stock analysis
Jump to another research area for this company.